These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8230084)

  • 1. RAA system and cardiovascular control in normal subjects, hypertensives and patients with congestive heart failure.
    Seravalle G; Cattaneo BM; Giannattasio C; Perondi R; Saino A; Grassi G; Mancia G
    J Hum Hypertens; 1993 Aug; 7 Suppl 2():S13-8. PubMed ID: 8230084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke).
    Laragh JH
    J Hum Hypertens; 1995 Jun; 9(6):385-90. PubMed ID: 7473515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The renin-angiotensin system: systemic and local function].
    Gohlke P; Ganten D; Lang RE; Unger T
    Z Kardiol; 1988; 77 Suppl 3():1-12. PubMed ID: 2850684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
    Sandmann S; Unger T
    Drugs; 2002; 62 Spec No 1():43-52. PubMed ID: 12036388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function.
    Esler M
    J Hypertens Suppl; 2002 Jun; 20(5):S13-9. PubMed ID: 12184059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure.
    Borghi C; Veronesi M; Cosentino E; Cicero AF; Kuria F; Dormi A; Ambrosioni E
    J Hypertens; 2007 Oct; 25(10):2051-7. PubMed ID: 17885547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial stiffness and the renin-angiotensin-aldosterone system.
    Mahmud A; Feely J
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):102-8. PubMed ID: 15526244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II as a cardiovascular risk factor.
    Gavras I; Gavras H
    J Hum Hypertens; 2002 May; 16 Suppl 2():S2-6. PubMed ID: 11967726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders.
    Fyhrquist F; Metsärinne K; Tikkanen I
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S19-24. PubMed ID: 8583476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localisation and physiological effects of tissue renin-angiotensin systems.
    Swales JD; Samani NJ
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():71-7. PubMed ID: 2674444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
    Castro-Chaves P; Leite-Moreira AF
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease.
    Mancia G; Dell'Oro R; Quarti-Trevano F; Scopelliti F; Grassi G
    J Hypertens Suppl; 2006 Mar; 24(1):S51-6. PubMed ID: 16601574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
    Sesin J; Tamargo J
    Medicina (B Aires); 1996; 56(1):75-84. PubMed ID: 8734937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baroreflexes and cardiovascular regulation in hypertension.
    Head GA
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S7-16. PubMed ID: 8642810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relation between cardiac hypertrophy and changes in the large arterial trunks. Role of the renin-angiotensin system].
    Benetos A
    Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():21-4. PubMed ID: 7646306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Left-ventricular hypertrophy as a cardiac risk factor: role of the renin-angiotensin-aldosterone system].
    Erne P
    Praxis (Bern 1994); 1996 Feb; 85(8):227-33. PubMed ID: 8701189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.